Evidence map›Paper›PMID 41430342›Full record

ArticleAddiction science & clinical practice2025

Implementing incentives in family medicine for opioid use disorder treatment: a qualitative inquiry on provider and patient preferences for a low magnitude reward program compatible with buprenorphine treatment.

Samantha Ellis, Jax Witzig, Diego Basaldu, Brittany Rudd, Nicole Gastala, Alexandra R Tabachnick, Sungha Kang, Tondalaya Henry, Nathan Stackhouse, Margaret Wardle

Abstract read
In one paragraph

Article in Addiction science & clinical practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Samantha EllisDepartment of Psychology, University of Illinois Chicago, 1007 W Harrison St, Chicago, IL, 60607, USA.
Jax WitzigDepartment of Psychiatry, University of Illinois College of Medicine Chicago, University of Illinois Chicago, Chicago, Illinois, USA.
Diego BasalduDepartment of Psychology, University of Illinois Chicago, 1007 W Harrison St, Chicago, IL, 60607, USA.
Brittany RuddDepartment of Psychiatry, University of Illinois College of Medicine Chicago, University of Illinois Chicago, Chicago, Illinois, USA.
Nicole GastalaDepartment of Family Medicine, Mile Square Health Centers, University of Illinois College of Medicine Chicago, Chicago, Illinois, USA.
Alexandra R TabachnickDepartment of Medical Social Sciences, Northwestern University, Evanston, Illinois, USA.
Sungha KangDepartment of Psychology, Loyola University Chicago, Chicago, Illinois, USA.
Tondalaya HenryDepartment of Family Medicine, Mile Square Health Centers, University of Illinois College of Medicine Chicago, Chicago, Illinois, USA.
Nathan StackhouseDepartment of Family Medicine, Mile Square Health Centers, University of Illinois College of Medicine Chicago, Chicago, Illinois, USA.
Margaret WardleDepartment of Psychology, University of Illinois Chicago, 1007 W Harrison St, Chicago, IL, 60607, USA. mwardle@uic.edu.

Funding

the National Institute of Health K08DA040006the University of Illinois Chicago Center for Clinical and Translational Science (CCTS) UL1TR002003
6 · The paper itself

Abstract

backgroundIncentive programs are an effective yet underutilized behavioral intervention that can improve outcomes in medication for opioid use disorder (MOUD) treatment. Contingency Management (CM) is a rigorous incentive program run per seven evidence-based principles (e.g. objectively verifiable target behaviors, frequent opportunities for incentives). Prior implementation attempts have focused on implementing CM in specialized addiction clinics with methadone as the primary medication treatment. However, many people get MOUD from less specialized, more accessible family medicine clinics. These clinics might also benefit from the use of incentive programs, yet present unique challenges for implementation. For example, family medicine clinics typically use buprenorphine as their primary medication, which requires less intensive dosing schedules than methadone and thus provides fewer incentive opportunities. As an initial step in user-centered design of a CM-informed incentive program for the family medicine context, we conducted qualitative interviews with patients and staff in the buprenorphine treatment program of a family medicine department. We gathered and analyzed qualitative data on CM knowledge, preferred program parameters, and implementation considerations.

methodParticipants (N = 24) were buprenorphine treatment staff (n = 12) and patients (n = 12). Participants completed 30-50-minute semi-structured interviews, analyzed using rapid matrix analysis.

resultsParticipants had little experience with formal incentive programs, but generally viewed incentives as acceptable, appropriate, and feasible. Interviewees coalesced around having staff who were not MOUD prescribers run the program, consistent rather than escalating payments, and physical rewards delivered in-person. Potential challenges included medical record integration, demands on staff time, and confirmation of patients' goal completion.

conclusionsPatient and staff feedback was well-aligned, especially regarding rewards as an opportunity for staff-patient connection and the need for simplicity. Comparing end-user suggestions with the literature, some consensus suggestions (e.g. non-escalating rewards) highlighted feasible places to compromise on ideal effectiveness to gain implementability. However, others (e.g. use of self-report to verify goals) conflicted directly with CM principles and indicate where more intensive education, support, and monitoring will be needed for implementation fidelity. These findings inform user-centered design and iteration of an incentive program for this accessible, non-specialized family medicine setting.

Indexed as

BuprenorphineFamily PracticeMotivationOpiate Substitution TreatmentOpioid-Related DisordersPatient PreferenceRewardAdultFemaleHumansMaleMiddle AgedNarcotic AntagonistsQualitative ResearchBuprenorphineNarcotic AntagonistsContingency managementMedication for opioid use disorderOpioid use disorderUser-centered design

Identifiers

PMID41430342
PMCPMC12723837

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.